Bank Of New York Mellon Corp Alkermes Plc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$26.4 - $32.56 $10.7 Million - $13.2 Million	-404,579 Reduced 12.31%	2,882,411 $78 Billion
Q4 2023 Jan 29, 2024	BUY	$23.37 - $28.68 $12.3 Million - $15.1 Million	525,674 Added 19.04%	3,286,990 $91.2 Billion
Q3 2023 Oct 24, 2023	BUY	$27.17 - $31.97 $2.9 Million - $3.41 Million	106,749 Added 4.02%	2,761,316 $77.3 Billion
Q2 2023 Aug 03, 2023	SELL	$28.34 - $33.63 $56,736 - $67,327	-2,002 Reduced 0.08%	2,654,567 $83.1 Billion
Q1 2023 May 09, 2023	BUY	$25.31 - $29.02 $67.2 Million - $77.1 Million	2,656,569 New	2,656,569 $74.9 Billion
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $54.8 Million - $65.5 Million	2,497,848 New	2,497,848 $65.3 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $192,236 - $278,480	-8,738 Reduced 0.35%	2,496,157 $55.7 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $2.18 Million - $2.52 Million	-82,413 Reduced 3.19%	2,504,895 $74.6 Million
Q1 2022 May 11, 2022	SELL	$23.07 - $27.99 $7.32 Million - $8.88 Million	-317,241 Reduced 10.92%	2,587,308 $68.1 Million
Q4 2021 Feb 11, 2022	BUY	$21.47 - $32.08 $3.01 Million - $4.5 Million	140,203 Added 5.07%	2,904,549 $67.6 Million
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $1.69 Million - $2.32 Million	72,340 Added 2.69%	2,764,346 $85.3 Million
Q2 2021 Aug 11, 2021	BUY	$18.78 - $25.15 $10.5 Million - $14.1 Million	558,943 Added 26.2%	2,692,006 $66 Million
Q1 2021 May 13, 2021	BUY	$18.21 - $23.2 $15.3 Million - $19.5 Million	838,832 Added 64.81%	2,133,063 $39.8 Million
Q4 2020 Feb 09, 2021	BUY	$15.39 - $22.1 $10.8 Million - $15.5 Million	700,898 Added 118.13%	1,294,231 $25.8 Million
Q3 2020 Nov 12, 2020	BUY	$16.16 - $20.66 $430,405 - $550,258	26,634 Added 4.7%	593,333 $9.83 Million
Q2 2020 Aug 12, 2020	BUY	$13.31 - $19.41 $102,167 - $148,991	7,676 Added 1.37%	566,699 $11 Million
Q1 2020 May 06, 2020	BUY	$13.06 - $21.24 $9,298 - $15,122	712 Added 0.13%	559,023 $8.06 Million
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $1.29 Million - $1.62 Million	-74,534 Reduced 11.78%	558,311 $11.4 Million
Q3 2019 Nov 07, 2019	BUY	$19.51 - $24.28 $224,169 - $278,977	11,490 Added 1.85%	632,845 $12.3 Million
Q2 2019 Aug 12, 2019	SELL	$21.47 - $37.33 $444,729 - $773,253	-20,714 Reduced 3.23%	621,355 $14 Million
Q1 2019 May 14, 2019	SELL	$28.4 - $36.49 $900,194 - $1.16 Million	-31,697 Reduced 4.7%	642,069 $23.4 Million
Q4 2018 Feb 11, 2019	SELL	$27.94 - $44.61 $14.2 Million - $22.7 Million	-509,581 Reduced 43.06%	673,766 $19.9 Million
Q3 2018 Nov 09, 2018	SELL	$38.6 - $46.12 $424,908 - $507,688	-11,008 Reduced 0.92%	1,183,347 $0
Q2 2018 Aug 06, 2018	SELL	$40.56 - $51.36 $1.26 Million - $1.59 Million	-30,981 Reduced 2.53%	1,194,355 $49.2 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $1.21 Million - $1.52 Million	-22,572 Reduced 1.81%	1,225,336 $71 Million
Q4 2017 Feb 09, 2018	BUY	$47.69 - $55.39 $59.5 Million - $69.1 Million	1,247,908	1,247,908 $68.3 Million

Others Institutions Holding ALKS

# of Institutions

361

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$546 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$374 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$364 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$264 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account